3655 NOBEL DRIVE, SAN DIEGO, CA
Announces Pricing of $6.0 Million Registered Direct Offering
Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women’s Health Strategy Advances
Reg. FD
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Investor Presentation
Stockholders Approve 2022 Stock Incentive Plan Amendment at Annual Meeting
Unregistered Sales of Equity Securities
Q2
Q1
FY 2025
Q3
FY 2024
S-1
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Regulation A Offering Circular Supplement (Annual Report)
QUALIF
Offering Statement - Qualified Offering Circular
Regulation A Offering Circular Supplement